Polsky 10: UtilityInnovation Group acquired for projected $2.6B | Aura Life Science joins ISS accelerator | OrisDX launches first diagnostic product - Polsky Center for Entrepreneurship and Innovation
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Deliver Oral Comments at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs